Rush Medical College is the medical school of Rush University, located in the Illinois Medical District, about 3 km west of the Loop in Chicago.

During the past decade, Rush Medical College conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Rush Medical College" are "Angelman Syndrome" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Chromosome 15q Duplication (dup15q) Syndrome" (1 trials), "Major Depressive Disorder" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Rush Medical College" in a lesser frequency.

Most popular intervention types in "Rush Medical College" are "Drug" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Collection" (1 trials), "Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator (DSF-rTMS)" (1 trials), "Lumbar Puncture" (1 trials), "TRAIL-R1 mAb (TRM-1;HGS-ETR1)" (1 trials) and "picoplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush Medical College" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rush Medical College". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rush Medical College, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush Medical College, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".